{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T12:30:08Z","timestamp":1793363408908,"version":"4.5.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T00:00:00Z","timestamp":1768521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T00:00:00Z","timestamp":1768521600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100022011","name":"Cancer Research UK Cambridge Institute, University of Cambridge","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100022011","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006775","name":"GE Healthcare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006775","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016309","name":"Bayer, United Kingdom","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016309","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Insights Imaging"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To evaluate patient acceptance and feedback regarding supplemental imaging modalities: automated whole-breast ultrasound (ABUS), contrast-enhanced mammography (CEM), and abbreviated breast MRI (AB-MRI) within the BRAID (Breast Screening: Risk Adaptive Imaging for Density) trial.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and methods<\/jats:title>\n                    <jats:p>An adapted Testing Morbidities Index questionnaire was utilised to capture participant experiences and perceptions (January-April 2024) related to AB-MRI, ABUS and CEM. Likert-scale questions assessed discomfort, anxiety, and overall satisfaction for each imaging modality, while thematic analysis was applied to free-text patient feedback. Additionally, reasons for withdrawal were recorded for each modality.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among 159 women providing feedback, 57\/159 (35.8%) underwent ABUS, 52\/159 (32.7%) CEM, and 50\/159 (31.5%) AB-MRI. Acceptability of ABUS, CEM and AB-MRI was rated similarly to mammography by 71\/159 (64.8%) of these respondents, with 72\/159 (45.3%) considering them superior. Mild-to-moderate discomfort due to breast compression was reported for ABUS and CEM, whereas AB-MRI resulted in the least discomfort. Pre-procedural anxiety was observed across all imaging modalities, particularly with contrast-enhanced techniques; however, experiences were generally well-tolerated. Effective communication and pre-test information reduced anxiety levels, with most participants willing to repeat the procedures. 151\/984 (15.3%) withdrawals in BRAID were due to adverse patient experiences, with contrast-enhanced techniques accounting for most of these withdrawals (CEM: 69\/151, 45.7%; AB-MRI: 66\/151, 43.7%; ABUS: 12\/151, 7.9%). The main reasons for withdrawal were unhappiness with the allocated imaging arm and discomfort or anxiety during the procedure.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Supplemental imaging modalities are generally well-accepted by patients with benefit throughout gained by clear communication and preparedness.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Critical relevance statement<\/jats:title>\n                    <jats:p>Feedback from a subgroup of women participating in the BRAID trial shows that supplemental imaging alongside routine screening is well-accepted. Clear communication and empathetic care further improve acceptance, supporting a shift toward personalised breast cancer screening for women with dense breasts.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Key Points<\/jats:title>\n                    <jats:p>\n                      <jats:list list-type=\"bullet\">\n                        <jats:list-item>\n                          <jats:p>Understanding women\u2019s imaging experiences is essential for optimising breast screening practices.<\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>Acceptability of supplemental imaging was rated similar to or better than mammography by most participants.<\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>Clear, empathetic communication reduced anxiety and improved experience with contrast-enhanced imaging.<\/jats:p>\n                        <\/jats:list-item>\n                      <\/jats:list>\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Graphical Abstract<\/jats:title>\n                  <\/jats:sec>","DOI":"10.1186\/s13244-025-02170-8","type":"journal-article","created":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T10:13:09Z","timestamp":1768558389000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Acceptance, experience, and feedback for supplemental screening in dense breasts among women participating in the BRAID trial"],"prefix":"10.1186","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6419-2422","authenticated-orcid":false,"given":"Iris","family":"Allajbeu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate R.","family":"Charnley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuyin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna","family":"Field-Rayner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsten","family":"Morris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas R.","family":"Payne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fleur","family":"Kilburn-Toppin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roido","family":"Manavaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona J.","family":"Gilbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,16]]},"reference":[{"key":"2170_CR1","unstructured":"NHS Breast Screening Programme (2025) Breast screening programme, England, 2023-24. NHS Digital. Available via https:\/\/digital.nhs.uk\/data-and-information\/publications\/statistical\/breast-screening-programme\/england---2023-24. Accessed 12 May 2025"},{"key":"2170_CR2","doi-asserted-by":"crossref","unstructured":"Independent UK Panel on Breast Cancer Screening (2012) The benefits and harms of breast cancer screening: an independent review. Lancet 380:1778\u20131786","DOI":"10.1016\/S0140-6736(12)61611-0"},{"key":"2170_CR3","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1158\/1055-9965.EPI-06-0034","volume":"15","author":"VA McCormack","year":"2006","unstructured":"McCormack VA, dos Santos Silva I (2006) Breast density and parenchymal patterns as markers of breast cancer risk: a meta-analysis. Cancer Epidemiol Biomark Prev 15:1159\u20131169","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"2170_CR4","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/s00330-024-10951-w","volume":"35","author":"NR Payne","year":"2025","unstructured":"Payne NR, Hickman SE, Black R, Priest AN, Hudson S, Gilbert FJ (2025) Breast density effect on the sensitivity of digital screening mammography in a UK cohort. Eur Radiol 35:177\u2013187","journal-title":"Eur Radiol"},{"key":"2170_CR5","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/j.crad.2021.02.013","volume":"76","author":"FJ Gilbert","year":"2021","unstructured":"Gilbert FJ, Hickman SE, Baxter GC et al (2021) Opportunities in cancer imaging: risk-adapted breast imaging in screening. Clin Radiol 76:763\u2013773","journal-title":"Clin Radiol"},{"key":"2170_CR6","doi-asserted-by":"crossref","unstructured":"Gilbert FJ, Payne NR, Allajbeu I et al (2025) Comparison of supplemental imaging techniques\u2014results of BRAID (Breast Screening: Risk Adapted Imaging for Density) randomized controlled trial. Lancet 405:1935\u20131944","DOI":"10.1016\/S0140-6736(25)00582-3"},{"key":"2170_CR7","first-page":"e12580","volume":"26","author":"P Whelehan","year":"2017","unstructured":"Whelehan P, Evans A, Ozakinci G (2017) Client and practitioner perspectives on the screening mammography experience. Eur J Cancer Care 26:e12580","journal-title":"Eur J Cancer Care"},{"key":"2170_CR8","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1080\/07399330390170015","volume":"24","author":"EL Hamilton","year":"2003","unstructured":"Hamilton EL, Wallis MG, Barlow J, Cullen L, Wright C (2003) Women\u2019s views of a breast screening service. Health Care Women Int 24:40\u201348","journal-title":"Health Care Women Int"},{"key":"2170_CR9","doi-asserted-by":"publisher","DOI":"10.1186\/s12913-023-09410-x","volume":"23","author":"OA Bolarinwa","year":"2023","unstructured":"Bolarinwa OA, Holt N (2023) Barriers to breast and cervical cancer screening uptake among Black, Asian, and Minority Ethnic women in the United Kingdom: evidence from a mixed-methods systematic review. BMC Health Serv Res 23:390","journal-title":"BMC Health Serv Res"},{"key":"2170_CR10","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1093\/pubmed\/fdt002","volume":"35","author":"EA Davies","year":"2013","unstructured":"Davies EA (2013) Socioeconomic and ethnic inequalities in screen-detected breast cancer in London. J Public Health 35:607\u2013615","journal-title":"J Public Health"},{"key":"2170_CR11","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1177\/0969141317699440","volume":"25","author":"AJ Chorley","year":"2018","unstructured":"Chorley AJ (2018) Public understanding of the purpose of cancer screening: a population-based survey. J Med Screen 25:64\u201369","journal-title":"J Med Screen"},{"key":"2170_CR12","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1186\/s13244-024-01868-5","volume":"15","author":"C Beardmore","year":"2024","unstructured":"Beardmore C, England A, Cruwys C, Carri\u00e9 D, European Federation of Radiographer Societies, and the European Society of Radiology (2024) How can effective communication help radiographers meet the expectations of patients\u2014COMMUNICATION\u2014a joint statement by the ESR & EFRS. Insights Imaging 15:300","journal-title":"Insights Imaging"},{"key":"2170_CR13","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1177\/0272989X13487605","volume":"33","author":"JS Swan","year":"2013","unstructured":"Swan JS, Kong CY, Lee JM et al (2013) Patient and societal value functions for the testing morbidities index. Med Decis Mak 33:819\u2013838","journal-title":"Med Decis Mak"},{"key":"2170_CR14","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1300\/J013v42n04_02","volume":"42","author":"KK Engelman","year":"2005","unstructured":"Engelman KK, Cizik AM, Ellerbeck EF (2005) Women\u2019s satisfaction with their mammography experience: results of a qualitative study. Women Health 42:17\u201335","journal-title":"Women Health"},{"key":"2170_CR15","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1016\/j.socscimed.2007.04.009","volume":"65","author":"RG Jepson","year":"2007","unstructured":"Jepson RG, Hewison J, Thompson A, Weller D (2007) Patient perspectives on information and choice in cancer screening: a qualitative study in the UK. Soc Sci Med 65:890\u2013899","journal-title":"Soc Sci Med"},{"key":"2170_CR16","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1002\/pon.5041","volume":"28","author":"AG Mathioudakis","year":"2019","unstructured":"Mathioudakis AG, Salakari M, Pylkkanen L et al (2019) Systematic review on women\u2019s values and preferences concerning breast cancer screening and diagnostic services. Psychooncology 28:939\u2013947","journal-title":"Psychooncology"},{"key":"2170_CR17","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1007\/s00330-009-1588-y","volume":"20","author":"KM Kelly","year":"2010","unstructured":"Kelly KM, Dean J, Comulada WS, Lee SJ (2010) Breast cancer detection using automated whole breast ultrasound and mammography in radiographically dense breasts. Eur Radiol 20:734\u2013742","journal-title":"Eur Radiol"},{"key":"2170_CR18","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1148\/radiol.14132832","volume":"274","author":"RF Brem","year":"2015","unstructured":"Brem RF, Tab\u00e1r L, Duffy SW et al (2015) Assessing improvement in detection of breast cancer with three-dimensional automated breast US in women with dense breast tissue: the SomoInsight study. Radiology 274:663\u2013673","journal-title":"Radiology"},{"key":"2170_CR19","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/s12609-021-00423-1","volume":"13","author":"I Allajbeu","year":"2021","unstructured":"Allajbeu I, Hickman SE, Payne N et al (2021) Automated breast ultrasound: technical aspects, impact on breast screening, and future perspectives. Curr Breast Cancer Rep 13:141\u2013150","journal-title":"Curr Breast Cancer Rep"},{"key":"2170_CR20","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1111\/1754-9485.12296","volume":"59","author":"MM Hobbs","year":"2015","unstructured":"Hobbs MM, Taylor DB, Buzynski S, Peake RE (2015) Contrast-enhanced spectral mammography (CESM) and contrast enhanced MRI (CEMRI): patient preferences and tolerance. J Med Imaging Radiat Oncol 59:300\u2013305","journal-title":"J Med Imaging Radiat Oncol"},{"key":"2170_CR21","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.clinimag.2016.12.011","volume":"42","author":"J Phillips","year":"2017","unstructured":"Phillips J, Miller MM, Mehta TS et al (2017) Contrast-enhanced spectral mammography (CESM) versus MRI in the high-risk screening setting: patient preferences and attitudes. Clin Imaging 42:193\u2013197","journal-title":"Clin Imaging"},{"key":"2170_CR22","doi-asserted-by":"publisher","first-page":"1762","DOI":"10.1007\/s00330-018-5668-8","volume":"29","author":"A Vourtsis","year":"2019","unstructured":"Vourtsis A, Berg WA (2019) Breast density implications and supplemental screening. Eur Radiol 29:1762\u20131777","journal-title":"Eur Radiol"},{"key":"2170_CR23","doi-asserted-by":"publisher","first-page":"4036","DOI":"10.1007\/s00330-022-08617-6","volume":"32","author":"RM Mann","year":"2022","unstructured":"Mann RM, Athanasiou A, Baltzer PAT et al (2022) Breast cancer screening in women with extremely dense breasts recommendations of the European Society of Breast Imaging (EUSOBI). Eur Radiol 32:4036\u20134045","journal-title":"Eur Radiol"},{"key":"2170_CR24","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.221785","volume":"306","author":"H Hussein","year":"2023","unstructured":"Hussein H, Abbas E, Keshavarzi S et al (2023) Supplemental breast cancer screening in women with dense breasts and negative mammography: a systematic review and meta-analysis. Radiology 306:e221785","journal-title":"Radiology"},{"key":"2170_CR25","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/j.clbc.2023.04.003","volume":"23","author":"F Lobig","year":"2023","unstructured":"Lobig F, Caleyachetty A, Forrester L et al (2023) Performance of supplemental imaging modalities for breast cancer in women with dense breasts: findings from an umbrella review and primary studies analysis. Clin Breast Cancer 23:478\u2013490","journal-title":"Clin Breast Cancer"},{"key":"2170_CR26","doi-asserted-by":"publisher","first-page":"6348","DOI":"10.1007\/s00330-024-10740-5","volume":"34","author":"M Marcon","year":"2024","unstructured":"Marcon M, Fuchsj\u00e4ger MH, Clauser P, Mann RM (2024) ESR Essentials: screening for breast cancer\u2014general recommendations by EUSOBI. Eur Radiol 34:6348\u20136357","journal-title":"Eur Radiol"}],"container-title":["Insights into Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13244-025-02170-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13244-025-02170-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13244-025-02170-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T10:13:14Z","timestamp":1768558394000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13244-025-02170-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,16]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2170"],"URL":"https:\/\/doi.org\/10.1186\/s13244-025-02170-8","relation":{},"ISSN":["1869-4101"],"issn-type":[{"value":"1869-4101","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,16]]},"assertion":[{"value":"28 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The BRAID (Breast Screening: Risk Adaptive Imaging for Density) trial (NCT04097366) received ethical approval from the National Research Ethics Service (NRES) Committee London \u2013 Surrey; REC no: 19\/LO\/0350. Additional approval for the service evaluation was provided by Cambridge University Hospitals NHS Foundation Trust (2024\/BR-117). All participants provided written informed consent prior to taking part.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent, including consent for publication, was obtained from all participants.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors of this manuscript declare relationships with the following companies: GE Healthcare, Bayer Healthcare.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"14"}}